October 31, 2019
HHSC seeks approval to enter into value-based supplemental rebate agreements with drug manufacturers based on outcome data or other metrics. Agreements must be consistent with federal law and approved by the Centers for Medicare and Medicaid Services as part of the Medicaid state plan. Agreements may include things of value, including, but not limited to:
- Price reduction
- Risk sharing
- Payment deferral or installment payments
- Patient care
- Shared savings payments
Instructions for drug manufacturers interested in participating in this rebate program will be available upon approval of the Medicaid state plan.